Healthcare M&A activity continued to build on the strong momentum from Q3 as the year concluded with the largest Q4 in both deal volume and value in the past six years. Deals that had been impacted by COVID-19 saw a concerted effort to close ahead of any potential changes to taxation policies. While several of…